Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data

Published:2024-04-12 Issue:5 Volume:40 Page:789-801
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Sinyavskaya Liliya¹,Meche Aster²,Faucher Ariane¹,Hlavacek Patrick³,Johnson Sarasa M. A.¹,DiBonaventura Marco³,Vekeman Francis¹,Ren Jinma⁴,Schepart Alex⁵

Affiliation:

1. STATLOG Inc, Montreal, Canada

2. Real World Evidence Center of Excellence, Pfizer Inc, New York, NY, USA

3. Value and Evidence, Pfizer Inc, New York, NY, USA

4. Statistical Research and Data Science Center, Pfizer Inc, Collegeville, PA, USA

5. US Medical Affairs, Pfizer Inc, New York, NY, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2333439

Reference35 articles.

1. Real-world treatment patterns, healthcare use and costs in triple-class exposed relapsed and refractory multiple myeloma patients in the USA

2. Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies

3. Treatment options for relapsed and refractory multiple myeloma

4. Treatment Options for Triple-class Refractory Multiple Myeloma

5. Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP